A new under-the-skin formulation of Ocrevus (ocrelizumab) — administered in 10 minutes — is at least as effective as…
Articles by Marisa Wexler, MS
Infection with the Epstein-Barr virus (EBV) may prime the immune system to accidentally attack a brain protein called ANO2,…
Six months of treatment with the experimental oral therapy vidofludimus calcium (IMU-838) led to significant reductions in a marker…
Most disability worsening events happen independent of relapse activity across all types of multiple sclerosis (MS), including clinically…
Problems with sexual dysfunction are a concern for multiple sclerosis (MS) patients of all ages, but the issues tend…
People with multiple sclerosis (MS) in the United Kingdom are less likely to be on disease-modifying treatments (DMTs)…
The expression of a viral protein known as W-Env leads to the inflammatory activation of brain cells and impairs myelin…
Among multiple sclerosis (MS) patients treated with Ocrevus (ocrelizumab), most of the disability worsening they experience is not…
Over more than a decade of treatment with Lemtrada (alemtuzumab), relapse rates were low and about half of people…
For older adults with multiple sclerosis (MS) who have highly active disease, most neurologists recommend starting treatment with a…
People with multiple sclerosis (MS) under treatment with Ocrevus (ocrelizumab) commonly experience fluctuations in the severity of their…
Researchers have identified nearly two dozen genes that help to control the movement of immune cells into the brain and…
Taking supplements of the sugar molecule N-acetylglucosamine, known as GlcNAc, was found to decrease markers of inflammation in people with…
Note: This story was updated Sept. 15, 2023, to clarify ANK-700 was developed based on the preclinical work described in…
A new statistical method could help to more accurately capture changes in disability severity for people with multiple sclerosis…
A protein called Daam2 helps to regulate the activity of cells in the brain that make myelin, the fatty covering…
A test that assesses the levels of 18 proteins in the blood and uses artificial intelligence algorithms can help to…
Noting that Aubagio (teriflunomide) continues to have “a robust impact on disability progression” in multiple sclerosis (MS) despite…
A new system that can use MRI scans to effectively measure myelin content in brain tissue may help assess…
Diagnosing primary progressive multiple sclerosis (PPMS) can be challenging, with obstacles ranging from ruling out other disorders to differentiating between…
The presence of lesions, or regions of damage, in a brain circuit tied to memory in stroke patients also associate…
Treatment with polysialic acid, a sugar molecule naturally made in the body, may be a promising approach to boost myelin…
Aubagio (teriflunomide) can significantly reduce the risk of developing multiple sclerosis (MS) among adults with signs of MS-like…
Researchers have shed new light on the molecular mechanisms that help immune cells get into the brain to drive inflammation…
People who experience a first attack of multiple sclerosis (MS)-like disease are less likely to experience long-term disability progression…
A higher quality diet is associated with reductions in certain types of brain lesions in multiple sclerosis (MS), but…
Immune cells in the skull’s bone marrow show distinct molecular profiles from those of other bones throughout the body, and…
An antibody biomarker may help to distinguish people with a disease that resembles multiple sclerosis (MS), but may actually…
A new imaging technique was able to detect inflammation in a mouse model of multiple sclerosis (MS) before disease…
Estimates of the prevalence of sexual dysfunction with multiple sclerosis (MS), as well of its risk factors, differ depending…